NASDAQ Biotechnology Index (NBI) Companies by Market Cap
The NASDAQ Biotechnology Index (NBI) tracks 263 constituent companies with a combined market cap of $1.67 Trillion, covering the largest publicly traded companies in USA. This ranking lists all NBI index holdings ordered by market capitalization — from the largest index heavyweights to smaller constituents. Updated daily with live market data.
Total Market Cap (USD)
$1.67 Trillion
Constituent Companies
263
Index Country
USA
| Rank | Company | Weight (%) | Market Cap (USD) | Sector | Industry | Price | 24h Change |
|---|---|---|---|---|---|---|---|
| 1 |
AstraZeneca PLC
NASDAQ:AZN |
% | $286.40 Billion | Healthcare | Drug Manufacturers - General | $184.74 | -1.40% |
| 2 |
Amgen Inc
NASDAQ:AMGN |
% | $177.77 Billion | Healthcare | Drug Manufacturers - General | $329.82 | -4.75% |
| 3 |
Gilead Sciences Inc
NASDAQ:GILD |
% | $163.34 Billion | Healthcare | Drug Manufacturers - General | $131.65 | +0.62% |
| 4 |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX |
% | $107.56 Billion | Healthcare | Biotechnology | $423.92 | -0.81% |
| 5 |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN |
% | $72.88 Billion | Healthcare | Biotechnology | $701.42 | -0.80% |
| 6 |
argenx NV ADR
NASDAQ:ARGX |
% | $45.97 Billion | Healthcare | Biotechnology | $787.95 | -0.66% |
| 7 |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY |
% | $39.27 Billion | Healthcare | Biotechnology | $296.11 | -4.32% |
| 8 |
Insmed Inc
NASDAQ:INSM |
% | $28.42 Billion | Healthcare | Biotechnology | $133.26 | -2.25% |
| 9 |
Biogen Inc
NASDAQ:BIIB |
% | $27.45 Billion | Healthcare | Drug Manufacturers - General | $187.06 | -1.17% |
| 10 |
United Therapeutics Corporation
NASDAQ:UTHR |
% | $21.42 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $570.40 | -0.17% |
| 11 |
Royalty Pharma Plc
NASDAQ:RPRX |
% | $21.19 Billion | Healthcare | Biotechnology | $49.47 | -1.24% |
| 12 |
Roivant Sciences Ltd
NASDAQ:ROIV |
% | $19.92 Billion | Healthcare | Biotechnology | $27.83 | -2.45% |
| 13 |
Incyte Corporation
NASDAQ:INCY |
% | $19.29 Billion | Healthcare | Biotechnology | $96.91 | +1.72% |
| 14 |
Revolution Medicines Inc
NASDAQ:RVMD |
% | $18.62 Billion | Healthcare | Biotechnology | $139.48 | -3.22% |
| 15 |
Illumina Inc
NASDAQ:ILMN |
% | $18.34 Billion | Healthcare | Diagnostics & Research | $135.78 | +7.13% |
| 16 |
Moderna Inc
NASDAQ:MRNA |
% | $17.99 Billion | Healthcare | Biotechnology | $45.37 | -1.24% |
| 17 |
Viatris Inc
NASDAQ:VTRS |
% | $17.32 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $15.04 | +0.67% |
| 18 |
Genmab AS
NASDAQ:GMAB |
% | $16.24 Billion | Healthcare | Biotechnology | $26.45 | -0.26% |
| 19 |
Ascendis Pharma AS
NASDAQ:ASND |
% | $13.56 Billion | Healthcare | Biotechnology | $220.93 | -3.68% |
| 20 |
BridgeBio Pharma Inc
NASDAQ:BBIO |
% | $13.14 Billion | Healthcare | Biotechnology | $68.56 | -3.59% |
| 21 |
Neurocrine Biosciences Inc
NASDAQ:NBIX |
% | $13.03 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $131.78 | +0.08% |
| 22 |
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ |
% | $12.20 Billion | Healthcare | Biotechnology | $202.72 | -0.15% |
| 23 |
Ionis Pharmaceuticals Inc
NASDAQ:IONS |
% | $12.19 Billion | Healthcare | Biotechnology | $75.28 | +0.70% |
| 24 |
Medpace Holdings Inc
NASDAQ:MEDP |
% | $11.92 Billion | Healthcare | Diagnostics & Research | $417.54 | -0.27% |
| 25 |
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL |
% | $11.90 Billion | Healthcare | Biotechnology | $518.74 | -1.97% |
| 26 |
Exelixis Inc
NASDAQ:EXEL |
% | $11.34 Billion | Healthcare | Biotechnology | $43.68 | -1.75% |
| 27 |
Summit Therapeutics PLC
NASDAQ:SMMT |
% | $11.14 Billion | Healthcare | Biotechnology | $16.12 | -24.91% |
| 28 |
Guardant Health Inc
NASDAQ:GH |
% | $11.02 Billion | Healthcare | Diagnostics & Research | $87.60 | +0.60% |
| 29 |
Biomarin Pharmaceutical Inc
NASDAQ:BMRN |
% | $10.40 Billion | Healthcare | Biotechnology | $54.06 | +0.28% |
| 30 |
Tempus AI, Inc. Class A Common Stock
NASDAQ:TEM |
% | $9.34 Billion | Healthcare | Health Information Services | $55.00 | -0.87% |
| 31 |
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR |
% | $9.19 Billion | Healthcare | Biotechnology | $74.81 | +1.81% |
| 32 |
Praxis Precision Medicines Inc
NASDAQ:PRAX |
% | $8.92 Billion | Healthcare | Biotechnology | $324.20 | +1.68% |
| 33 |
Blueprint Medicines Corp
NASDAQ:BPMC |
% | $8.36 Billion | Healthcare | Biotechnology | $129.46 | +0.14% |
| 34 |
Vaxcyte Inc
NASDAQ:PCVX |
% | $8.19 Billion | Healthcare | Biotechnology | $56.93 | -0.54% |
| 35 |
Axsome Therapeutics Inc
NASDAQ:AXSM |
% | $7.88 Billion | Healthcare | Biotechnology | $206.53 | -0.59% |
| 36 |
Krystal Biotech Inc
NASDAQ:KRYS |
% | $7.71 Billion | Healthcare | Biotechnology | $266.04 | +1.44% |
| 37 |
Halozyme Therapeutics Inc
NASDAQ:HALO |
% | $7.52 Billion | Healthcare | Biotechnology | $63.96 | +0.47% |
| 38 |
Cytokinetics Inc
NASDAQ:CYTK |
% | $7.39 Billion | Healthcare | Biotechnology | $63.35 | -0.97% |
| 39 |
Verona Pharma PLC ADR
NASDAQ:VRNA |
% | $7.31 Billion | Healthcare | Biotechnology | $86.00 | +0.00% |
| 40 |
Merus BV
NASDAQ:MRUS |
% | $6.83 Billion | Healthcare | Biotechnology | $90.00 | -7.14% |
| 41 |
Nuvalent Inc
NASDAQ:NUVL |
% | $6.66 Billion | Healthcare | Biotechnology | $99.04 | -1.24% |
| 42 |
Kymera Therapeutics Inc
NASDAQ:KYMR |
% | $6.32 Billion | Healthcare | Biotechnology | $80.71 | -0.44% |
| 43 |
Centessa Pharmaceuticals PLC ADR
NASDAQ:CNTA |
% | $6.10 Billion | Healthcare | Biotechnology | $39.43 | -0.10% |
| 44 |
Immunitybio Inc
NASDAQ:IBRX |
% | $5.96 Billion | Healthcare | Biotechnology | $7.11 | +0.14% |
| 45 |
Cogent Biosciences Inc
NASDAQ:COGT |
% | $5.86 Billion | Healthcare | Biotechnology | $36.63 | +2.35% |
| 46 |
Mirum Pharmaceuticals Inc
NASDAQ:MIRM |
% | $5.82 Billion | Healthcare | Biotechnology | $96.53 | -0.80% |
| 47 |
CG Oncology, Inc. Common stock
NASDAQ:CGON |
% | $5.60 Billion | Healthcare | Biotechnology | $66.27 | -0.70% |
| 48 |
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM |
% | $5.59 Billion | Healthcare | Biotechnology | $81.81 | +0.55% |
| 49 |
PTC Therapeutics Inc
NASDAQ:PTCT |
% | $5.39 Billion | Healthcare | Biotechnology | $65.15 | +0.14% |
| 50 |
Immunovant Inc
NASDAQ:IMVT |
% | $5.24 Billion | Healthcare | Biotechnology | $27.12 | -0.09% |
Complete list of all companies in the NBI index ranked by market capitalization. Track index constituent performance and market values. View all indices